
Dr Boreham’s Crucible: The wheels keep turning for Dimerix and its kidney drug candidate
Tim Boreham is one of Australia's best-known small-cap share analysts and business journalists. As a former bus driver, Dimerix (ASX:DXB) CEO Dr Nina Webster knows that the drug development journey is just as important as the destination when it comes …